SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IRLA

IRulya Therapeutics Inc. (NASDAQ:IRLA)

US · Delayed Price · Currency is USD
Also listed: QNCXHealthcare · Biotechnology
$39.78+$1.45 (+3.78%)
 
Market cap
$40.5M
Insider Score
Health Score
Analyst consensus
Listed since
May 9, 2019
Insider Score
––Not scored
IRLA Insider Score

Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

IRLA analyst forecast

IRLA analyst consensus

Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

IRLA 12-month price target

$70.00+76.0% upsideaverage of 1 firm
$70.00High
$70.00Low

Best analysts covering IRLA

Every firm covering IRLA has a measured record, but none of them has a Buy or Sell on it from the last 12 months — only a Hold, which is not a directional call and is left out of the ranking.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

IRLA analyst ratings

FirmPrice targetAction
—CitizensMarket Outperform——Upgraded2026-09-22
Cantor FitzgeraldOverweight$70.00+112.7%Reiterated2026-08-18
—OppenheimerOutperform——Reiterated2026-07-29

IRLA earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-04-06-$3.59-$3.50$0$0
2026-05-12-$26.00$75.60$0$0
2026-08-14-$28.02-$12.31$0$0
2026-11-11-$1.39$0.00$0$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.